期刊文献+

支气管肺泡灌洗液与胸腔积液细胞学对良、恶性胸腔积液的诊断价值

Bronchoalveolar lavage fluid and pleural effusion cytol ogy indiagnosis of benign and malignant pleural effusion
下载PDF
导出
摘要 目的 探讨支气管肺泡灌洗液 (BALF)与胸腔积液细胞学对良性与恶性胸腔积液的鉴别方法。方法 对 42例胸腔积液患者进行BALF与胸腔积液细胞学及 pH、乳酸脱氢酶 (LDH )、癌胚抗原 (CEA)检测对比分析。 结果 间质细胞、巨噬细胞计数在BALF和胸腔积液结核组低于肿瘤组 (P均 <0 .0 1) ;BALF与胸腔积液中发现肿瘤细胞分别为 0 .10 2± 0 .0 47和 0 .14 0± 0 .0 5 3 (P >0 .0 5 ) ,两者的 pH、LDH、CEA水平比较差异无显著性 (P 均 >0 .0 5 )。结论 BALF与胸腔积液间质细胞和巨噬细胞检测对良性与恶性胸腔积液有重要的诊断与鉴别诊断价值 ,pH、LDH、CEA水平异常升高对恶性胸水的早期诊断有临床意义。 Objective To investigate the va lu e of bronchoalveolar lavage fluid (BALF) and pleural effusion cytology in diagno sis and differentiatial diagnosis of benign and malignant pleural effusion. Methods The BALF and pleural effusion cytology and pH, LDH and CEA from 42 patients with pleural effusion were comparatively analyz ed. Results The Leydig cells and macrophage cou nt in BALF group and pleural effusion tuberculosis group were all lower than tho se in the tumor group (all P<0.01); the tumor cells in BALF and pleural effu sion were 0.102±0.047 and 0.140±0.053, respectively (P>0.05), there were n o statistically significant differences in comparison of pH, LDH, CEA in these t wo groups (all P>0.05). Conclusion BALF and Leydig cells of pleural effusion and macrophage are important in diagnosis and differential diagnosis of benign and malignant pleural effusion, the abnormal el evation of pH, LDH and CEA levels is of clinical significance in early diagnosis of malignant pleural effusion.
出处 《右江民族医学院学报》 2004年第6期796-798,共3页 Journal of Youjiang Medical University for Nationalities
关键词 支气管肺泡灌洗液 胸腔积液 细胞学 实验室诊断 诊断 bronchoalveolar lavage fluid pleur al effusion cytology laboratory diagnosis diagnosis
  • 相关文献

参考文献3

二级参考文献10

  • 1Dohmoto k, Hojo S, Fujita J, et al. The role of caspase 3 in producing cytokeratin 19 fragment (CYFRA21-1) in human lung cancer cell lines[J]. Int J Cancer, 2001, 91(4): 468-473
  • 2Dohmoto K, Hojo S, Fujita J, et al. Mechanisms of the release of CYFRA21-1 in human lung cancer cell lines [J].Lung Cancer,2000, 30(1): 55-63
  • 3Ando S, Kimura H, Iwai N, et al. Positive reaction for both Cyfra21-1 and CA125 indicate worst prognosis in non-small cell lung cancer[J]. Antican-cer Res, 2003, 23(3c): 2869-2874
  • 4Reinmuth N, Brandt B, Semik M, et al. Prognostic impact of Cyfra21-1 and other serum markers in completely resected nonsmall cell cancer(L)[J]. Lung Cancer, 2002, 36(3): 265-270
  • 5TrapeJ, BuxoJ, Perez de Olaguer, et al. Tumor markers as prognostic factors in treated non-small cell lung cancer[J].Anticancer Res, 2003, 23(5b): 4277-4281
  • 6Cioffi M, Vietri M, Gazzerro P, et al. Serum anti-p53 antibodies in lung cancer:comparison with established tumor markers [J].Lung Cancer, 2001, 33(2-3): 163-169
  • 7Kanazawa H, Yoshikawa T, Yamada M, et al. CYFRA21-1,a cytokeratin subunit 19 fragment,in bronchoalveolar lavage fluid from patients with interstitial lung disease [J]. Clin Sci (Lond),1998, 94(5):531-535
  • 8李振华 赵洪文 孔灵菲.支气管肺泡灌洗对肺部肿瘤诊断价值的探讨[J].中华结核和呼吸杂志,1996,19(5):26-26.
  • 9林其昌,林晓,陈公平,陈美云,潘玉凤.支气管肺泡灌洗液肿瘤标志物联合检测诊断肺癌的研究[J].中国内镜杂志,1999,5(4):3-5. 被引量:9
  • 10刘洪洲.非小细胞肺癌患者支气管肺泡灌洗液中可溶性细胞角蛋白19片段的检测[J].临床医学,2002,22(8):2-3. 被引量:4

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部